HIT on Nasdaq

Health In Tech, Inc.

Health In Tech, Inc. is an insurance agents company, listed on Nasdaq (HIT).1 It is headquartered in Stuart, Florida.1

Price unavailable

Last updated Oct 20, 2026.

Overview

$33.3MRevenue, fiscal 20252
$1.3MNet income, fiscal 20252

Compare with Zhibao Technology Inc., XChange TEC.INC or QDM International Inc., or pick any stock.

  • TickerHIT on Nasdaq1
  • IndustryInsurance Agents, Brokers & Service1
  • HeadquartersStuart, Florida1
  • Business address701 S. Colorado Ave, Suite 1, Stuart, Fl 349943
  • Filer category, Emerging growth company3

See how the biggest companies compare on our leaderboards

“Carrier” refers to an insurance company or insurer that provides stop loss insurance.4 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

62.8%Gross margin2
3.8%Net margin2
71.0%Revenue growth, 20252
7.5%Return on equity2

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Products and services

SMRMember brought in 45% of the revenue Health In Tech, Inc. broke down this way in fiscal 2025.

  1. SMRMember$26.8M245%up 169% from 2024
  2. Revenues From Fees$26.5M244%up 106% from 2024
  3. Revenues From Underwriting Modeling ICEMember$6.9M211%up 3% from 2024
Products and services by year
Products and services20242025
SMRMember$9.9M$26.8M
Revenues From Fees$12.8M$26.5M
Revenues From Underwriting Modeling ICEMember$6.6M$6.9M

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue37¢$12.4M
  • Research and development5¢$1.6M
  • Other costs53¢$17.7M
  • Income tax1¢$395.3K
  • Profit4¢$1.3M

Out of $33.3M in revenue.2

Where each dollar of operating cash went, fiscal 2025

  • Kept or used elsewhere100¢$3.1M

Out of $3.1M of cash from operations.2

Financial statements

Revenue52$33.3M in 2025+74% since 2023
0$10.0M$20.0M$30.0M$40.0M2023: $19.2M$19.2M20232024: $19.5M$19.5M2024+2%2025: $33.3M$33.3M2025+71%
Gross profit52$20.9M in 2025+24% since 2023
0$10.0M$20.0M$30.0M2023: $16.8M$16.8M20232024: $15.4M$15.4M2024−8%2025: $20.9M$20.9M2025+36%
Net income52$1.3M in 2025−68% since 2023
0$1.0M$2.0M$3.0M$4.0M2023: $4.0M$4.0M20232024: $670.5K$670.5K2024−83%2025: $1.3M$1.3M2025+91%

Every line of the income statement as filed: the last 2 fiscal years, latest first.2

Period ending2025-12-312024-12-31
Total revenues$33.3M$19.5M
Cost of revenues$12.4M$4.1M
Gross profit$20.9M$15.4M
Sales and marketing expenses$4.2M$3.2M
General and administrative expenses$13.7M$8.5M
Research and development expenses$1.6M$2.8M
Total operating expenses$19.4M$14.4M
Interest income$409.9K$122.9K
Interest expenses-$495.0K
Other income$118.4K$271.2K
Other expense-$382.6K
Total other income (expense), net$145.7K-$100.9K
Income before income tax expense$1.7M$889.0K
Provision for income taxes-$395.3K-$218.5K
Net income$1.3M$670.5K
Basic (in Dollars per share)$0.02$0.01
Diluted (in Dollars per share)$0.02$0.01
Basic (in Shares)55.8M shares51.8M shares
Diluted (in Shares)57.7M shares53.7M shares

Compare Health In Tech, Inc. with another company

Corporate structure

Health In Tech, Inc. sits at the top of its group. 1 entity on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Health In Tech, Inc.

  • Laurence W. Lytton Filed SCHEDULE 13G on Health In Tech, Inc., latest Sep 29, 2026
  • Zhong Yang Securities Ltd Filed SCHEDULE 13G/A on Health In Tech, Inc., latest Feb 27, 2025 (2 filings since Feb 13, 2025)
  • Linlin Qian Filed SCHEDULE 13G on Health In Tech, Inc., latest Feb 14, 2025
  • Tim Donald Johnson Filed SCHEDULE 13G on Health In Tech, Inc., latest Feb 14, 2025
  • Health In Tech, Inc. Stuart, Florida

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Health In Tech, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Operating-lease assets (leased space)$139.9K2 Dec 31, 2025$206.3K2 Dec 31, 2024−32.2%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$7.7M2 Dec 31, 2025$7.8M2 Dec 31, 2024−2.3%

Properties, in its own words

Our principal office is located at 701 S. Colorado Ave, Suite 1, Stuart, FL 34994, where we lease approximately 4,900 square feet of space under lease agreements for our business operations expiring in October 2027. We believe our existing facilities are adequate to meet our current requirements.

Item 2 of the 10-K filed Mar 25, 2026.4

Leadership

Who has led Health In Tech, Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Linlin Qian2026–now

Chief financial officer

  1. Linlin Qian2024–now

Chief operating officer

  1. Jonathan Del Lockett2024
  2. Chris Allen Kurtenbach2025–now
2025
Board members and other officers (15)

Timeline

  1. Sep 30, 20268-K Regulation FD disclosure28
  2. Sep 16, 2026New chief executive Linlin Qian becomes CEO10
  3. Aug 13, 20268-K Results of operations; Regulation FD disclosure29
  4. Aug 13, 20268-K Regulation FD disclosure30
  5. Aug 13, 20268-K Regulation FD disclosure31
  6. May 14, 20268-K Regulation FD disclosure32
  7. May 13, 20268-K Results of operations; Regulation FD disclosure33
  8. May 13, 20268-K Regulation FD disclosure34
  9. May 1, 20268-K Executive or director change35
  10. Mar 27, 20268-K Entered a material agreement36
  11. Mar 27, 20268-K Regulation FD disclosure37
  12. Mar 26, 20268-K Entered a material agreement; Unregistered sale of shares; Regulation FD disclosure38
  13. Mar 25, 20268-K Results of operations; Regulation FD disclosure39

Calendar

Coming up

  1. Nov 9, 2026Reports results for the quarter ending Sep/2026 A year earlier it reported $0.01 a share, on Nov 10, 2025.40

When it reported results

  1. Aug 13, 2026Reported quarterly or annual results29
  2. May 13, 2026Reported quarterly or annual results33
  3. Mar 25, 2026Reported quarterly or annual results39
  4. Nov 12, 2025Reported quarterly or annual results41
  5. Jul 21, 2025Reported quarterly or annual results42
  6. Apr 14, 2025Reported quarterly or annual results43
  7. Mar 17, 2025Reported quarterly or annual results44

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

166 filings to the SEC since October 2021: 2 annual reports, 5 quarterly reports, 32 major events, 69 insider forms, 5 large holders, 53 other. The latest 20:

  1. Oct 13, 2026ARS EDGAR
  2. Oct 13, 2026DEF 14A PROXY STATEMENT EDGAR
  3. Oct 13, 2026S-3/A AMENDMENT NO. 1 TO FORM S-3 EDGAR
  4. Oct 9, 20264 EDGAR
  5. Oct 9, 20264 EDGAR
  6. Oct 1, 2026PRE 14A PROXY STATEMENT EDGAR
  7. Sep 30, 20268-K CURRENT REPORT EDGAR
  8. Sep 29, 2026SCHEDULE 13G EDGAR
  9. Sep 16, 20264 EDGAR
  10. Sep 16, 20264 EDGAR
  11. Sep 16, 20264 EDGAR
  12. Sep 15, 20264 OWNERSHIP DOCUMENT EDGAR
  13. Sep 14, 2026144 EDGAR
  14. Sep 14, 2026144 EDGAR
  15. Sep 14, 20264 EDGAR
  16. Sep 11, 20264 EDGAR
  17. Sep 10, 2026144 EDGAR
  18. Sep 4, 2026S-3 REGISTRATION STATEMENT EDGAR
  19. Aug 17, 20264 EDGAR
  20. Aug 17, 20264 EDGAR

The 166 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

4 open-market trades by officers, directors and large owners since October 2021: 0 buys and 4 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Sep 14, 2026Hayes TimothyDirectorSale12,000$0.89$10.7KForm 4
Sep 11, 2026Hasan Zain SyedChief Growth OfficerSale11,667$0.92$10.7KForm 4
Sep 11, 2026Hayes TimothyDirectorSale12,000$0.91$10.9KForm 4
Sep 9, 2026Hayes TimothyDirectorSale5,730$0.93$5.3KForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

  • Laurence W. LyttonSCHEDULE 13G, 1 filing Sep 29, 202645
  • Zhong Yang Securities LtdSCHEDULE 13G/A, 2 filings Feb 13, 2025 to Feb 27, 202546
  • Linlin QianSCHEDULE 13G, 1 filing Feb 14, 202547
  • Tim Donald JohnsonSCHEDULE 13G, 1 filing Feb 14, 202548

Executive pay

What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.

YearExecutiveAgeSalaryTotal pay
2025Tim Johnson61$420.0K$814.9K49
2025Julia (Linlin) Qian51$360.0K$730.2K49
2025Dustin Plantholt$231.7K$417.1K49
2024Chief Executive Officer$420.0K$466.5K49
2024Chief Financial Officer$360.0K$407.5K49

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Whetstone Capital Advisors, LLC1,509,766$1.5M0.4%New
Mink Brook Asset Management LLC1,133,369$1.1M0.5%+326,908
Vanguard Capital Management LLC568,475$574.2K0.0%+3,000
Heights Capital Management, Inc350,268$353.8K0.1%−23,030
BlackRock, Inc.349,595$353.1K0.0%+64,940
Geode Capital Management, LLC220,650$222.9K0.0%+37,325
Citadel Advisors LLC176,911$178.7K0.0%+140,279
Vanguard Fiduciary Trust Co130,482$131.8K0.0%+55,914
State Street Corp62,900$63.5K0.0%No change
Northern Trust Corp57,659$58.2K0.0%+21,509
XTX Topco Ltd22,898$23.1K0.0%−1,980
Two Sigma Securities, LLC18,667$18.9K0.0%New
StoneX Group Inc.14,264$14.3K0.0%New
LPL Financial LLC13,582$13.7K0.0%New
MN Wealth Advisors, LLC12,000$12.1K0.0%New
Qube Research & Technologies Ltd10,426$10.5K0.0%New
UBS Group AG5,223$5.3K0.0%−2,980
Tower Research Capital LLC (TRC)3,263$3.3K0.0%−1,294
Morgan Stanley962$9720.0%−13,747
Barclays PLC719$7260.0%New
Virtu Financial LLC15,072$150.0%New

13F reports cover disclosed long positions in U.S. stocks only.

SEC filer profile

How Health In Tech, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARHealth In Tech, Inc.1
  • CIK0002019505
  • Employer ID (EIN)87-35457224
  • Filer statusNon-accelerated filer an emerging growth company; a smaller reporting company; not a shell company4
  • Incorporated inNevada4
  • Fiscal year endsDecember 311
  • Industry code (SIC)6411 Insurance Agents, Brokers & Service1
  • SEC reviewing officeOffice of Finance, Division of Corporation Finance1
  • Business address701 S. Colorado Ave, Suite 1, Stuart, FL 349941
  • Phone888-373-03331
  • Shares outstanding48,258,276 Common Class A shares; 11,700,000 Common Class B shares as of Mar 25, 20264
  • Public float$12.7M as of Jun 30, 20254
  • AuditorMaloneBailey, LLP, Houston, Texas PCAOB ID 206; no auditor attestation of internal control over financial reporting4
  • On EDGAR sinceApr 19, 20241
  • Filings166 in all: 4 (50), 8-K (32), 3 (18), UPLOAD (7), CORRESP (6), S-1/A (6), 10-Q (5), SCHEDULE 13G (4)1
    All 29 form types

    144 (3), 424B3 (3), DRS/A (3), DRSLTR (3), EFFECT (3), S-3 (3), S-3/A (3), 10-K (2), DEF 14A (2), FWP (2), 4/A (1), 424B4 (1), 8-A12B (1), ARS (1), CERT (1), DEFA14A (1), DRS (1), PRE 14A (1), S-1 (1), S-8 (1), SCHEDULE 13G/A (1)

  • Latest filingsAnnual report (10-K) Mar 25, 2026
    Quarterly report (10-Q) Aug 13, 2026
    Proxy statement (DEF 14A) Oct 13, 2026
    Latest 8-K (8-K) Sep 30, 2026

Securities registered for trading

ClassSymbolExchange
Class A common stock, par value $0.001 per shareHITNasdaq

From the cover page of the 10-K filed Mar 25, 2026 (Section 12(b) of the Exchange Act).4

Risk factors and legal proceedings

The risks Health In Tech, Inc. names in Item 1A of its 10-K filed Mar 25, 2026: 38 risks under these headings, as written.4

  • Risks Related to our Business and Industry
  • Our success and ability to grow our business depend in part on retaining and expanding our network of brokers, TPAs MGUs, and other third-party agents. If we fail to add to our network, or retain our current one, our business, revenue, operating results, and financial condition could be harmed.
  • Our growth strategy includes, without limitation, the acquisition of additional clients in existing and new markets and states, introducing new services and plans, and monetizing our technology.
  • We rely on the ability of our insurance carriers to service our clients.
  • We may not be able to maintain profitability in the future.
  • Failure to accurately perform underwriting actuarial reviews and adjustments to our underwriting tools could result in an increase in the cost and pricing of health plans we are able to program in the future, which could negatively impact the reputation of our eDIYBS platform and our financial results.
  • Failure of HI Card to properly function and provide an interface for medical claims for clients on our platform could negatively affect our clients and could lead to them terminating our services.
  • If the number of members utilizing our platforms or the number of services to which they subscribe decreases, our revenue will decrease.
  • We rely on the health of the U.S. health insurance industry and benefits of self-insurance plans.
  • Changes or developments in the health insurance markets in the United States, including passage and implementation of a law to create a single-payer or government-run health insurance program, could materially and adversely harm our business and operating results.
  • If we fail to comply with applicable privacy, security, and data laws, regulations and standards, including with respect to third-party service providers that utilize sensitive personal information on our behalf, or applicable consumer protection laws, our business, reputation, results of operations, financial position, and cash flows could be materially and adversely affected.
  • Our limited operating history makes it difficult to evaluate our current business performance, implementation and growth of our business model, and our future prospects.
The other 27 risks
  • We are subject to risks associated with outsourcing services and functions to third parties.
  • If we are unable to integrate and manage our information systems effectively, our operations could be disrupted.
  • From time to time, we may become involved in costly and time-consuming litigation and regulatory actions, which require significant attention from our management.
  • We rely on the experience and expertise of our Founder, senior management team, highly-specialized technology and insurance experts, key technical employees, and other highly skilled personnel.
  • If we or our partners or other third parties with whom we collaborate sustain a cyber-attack or suffer privacy or data security breaches that disrupt our information systems or operations, or result in the dissemination of sensitive personal or confidential information, we could suffer increased costs, exposure to significant liability, adverse regulatory consequences, reputational harm, loss of business, and other serious negative consequences.
  • Our customers’ sensitive, proprietary, or confidential information could be leaked, disclosed, or revealed as a result of or in connection with our employees’, personnel’s, or vendors’ use of generative AI technologies.
  • Machine learning models may create incomplete, inaccurate, or otherwise flawed outputs, some of which may appear correct. Providing bindable quotes solely using AI-backed technology can lead to errors in the actual risk profile of the employee pool being insured, leading to higher insurance costs than originally anticipated during the quoting process.
  • There can be no assurances that our Artificial Intelligence Governance Policy and other measures will prevent risks related to our use of AI.
  • Real or perceived errors, failures or bugs in our systems, website, or app could impair our operations, damage our reputation and brand, and harm our business and operating results.
  • Failure to secure, protect, or enforce our intellectual property rights could harm our business, results of operations, and financial condition.
  • The use of open source software in our services and solutions may expose us to additional risks and harm our intellectual property rights.
  • We might require additional capital to support business growth.
  • Risks Related to Ownership of Our Class A Common Stock
  • Our Class A Common Stock price may be volatile or may decline regardless of our operating performance, and you may not be able to resell your shares at or above the initial public offering price.
  • The dual class structure of our common stock will have the effect of concentrating voting control with our Chief Executive Officer and Chief Financial Officer for the foreseeable future, which will limit the ability of our other investors to influence corporate matters, including the election of directors and the approval of any change of control transaction.
  • We cannot predict the effect our dual class structure may have on the market of our Class A Common Stock.
  • We do not intend to pay dividends on our Class A Common Stock for the foreseeable future.
  • Future sales or availability of our Class A Common Stock or rights to purchase our Class A Common Stock, including pursuant to our equity incentive plans, or other equity securities or securities convertible into our Class A Common Stock, including our Class B Common Stock, could result in additional dilution of the percentage ownership of our stockholders and could cause the stock price of our Class A Common Stock to decline.
  • The JOBS Act allows us to postpone the date by which we must comply with certain laws and regulations intended to protect investors, and to reduce the amount of information we provide in our reports filed with the SEC. We cannot be certain if this reduced disclosure will make our Class A Common Stock less attractive to investors.
  • Our management team has limited experience managing a public company.
  • The obligations associated with being a public company require significant resources and management attention, and we have and will continue to incur increased costs as a result of becoming a public company.
  • As a public reporting company, we are subject to rules and regulations established from time to time by the SEC regarding our internal control over financial reporting. If we fail to establish and maintain effective internal control over financial reporting and disclosure controls and procedures, we may not be able to accurately report our financial results, or report them in a timely manner.
  • Claims for indemnification by our directors and officers may reduce our available funds to satisfy successful stockholder claims against us and may reduce the amount of money available to us.
  • Provisions in our Bylaws and Nevada law may have the effect of discouraging lawsuits against our directors and officers.
  • Anti-takeover provisions in our governing documents and under Nevada law could make an acquisition of our company more difficult, limit attempts by our stockholders to replace or remove our current management, and depress the market price of our Class A Common Stock.
  • An active trading market for our Class A Common Stock may not be sustained.
  • If our operating and financial performance in any given period does not meet the guidance that we provide to the public, the market price of our Class A Common Stock may decline.
  • We are a “controlled company” within the meaning of the Nasdaq listing rules, and we may follow certain exemptions from certain corporate governance requirements that could adversely affect our shareholders.

Legal proceedings

We are not party to any material legal proceedings. We have in the past, and from time to time may be in the future, involved in legal proceedings or subject to claims incident to the ordinary course of business. Regardless of the outcome, such proceedings or claims can have an adverse impact on us because of defense and settlement costs, diversion of resources and other factors, and there can be no assurances that favorable outcomes will be obtained.

The opening of Item 3, Legal Proceedings.4

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49